ArticleScientific reports2026
Novel universal domain-centric method for protein classification.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human protein kinases constitute a large superfamily of about 500 genes, historically classified into subfamilies based on phylogenetic relationship. However, many kinases remain unclassified. Phylogeny is typically based on multiple sequence alignments, and neglects the physico-chemical properties of residues at each position of the sequence. By incorporating these properties, we can gain deeper insights beyond basic alignments. Here we use, for the first time, a detailed physico-chemical description of kinases to identify class-specific structural regions, supporting an unsupervised classification method capable of classifying previously unlabeled kinases. This novel approach aligns with existing phylogeny-based classifications while offering refinements and enhanced accuracy. Ultimately, we use machine learning techniques to classify unlabeled kinases, validated by analyzing class-specific structural regions. This new classification approach goes beyond current rankings and can be applied to any type of protein, such as immunoglobulins and G protein-coupled receptors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.